ES
Therapeutic Areas
ConvaTec Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Hydrofiber® EVOLUTION | Advanced Wound Care | Commercial |
| ConvaTec Innovation Initiative (CII) | Ostomy Care (Smart Devices) | R&D |
| me+™ Program Expansion | Patient Support Services | Roll-out |
| Neria™ Guard Infusion Sets | Subcutaneous Drug Delivery | Market Expansion |
| Advanced Skin Barrier Technologies | Ostomy & Continence Care | R&D |
Leadership Team at ConvaTec
KB
Karim Bitar
Chief Executive Officer
JC
John C. (Chris) Roberts
Non-Executive Chairman
JC
John C. (Chris) Mills
Chief Financial Officer
PP
Prakash Patel
Chief Operating Officer
CJ
Claire James
Chief People Officer
BD
Ben Duncan
Chief Commercial Officer
SG
Stuart G. (Graham) Hilditch
General Counsel & Company Secretary